The ability to induce MHC-II expression in transmissible tumour cells creates an avenue for vaccine and immunotherapeutic strategies to enhance anti-tumour immunity through CD4+ T cell help and inform of the importance of MHC-II in anti-tumour and allogeneic immune responses. The gene discussed is CD4; the disease is neoplasm.